Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Croda International ( (GB:CRDA) ) just unveiled an announcement.
Croda International chief executive Stephen Foots has exercised conditional share awards granted in March 2023 under the company’s Performance Share Plan and Deferred Bonus Share Plan. The awards covered 1,500 and 6,178 ordinary shares respectively, both at nil cost.
To meet associated tax liabilities, Foots sold a total of 3,622 shares on 17 March at £26.057 each on the London Stock Exchange. The transaction underscores ongoing use of equity-based remuneration for senior management but does not signal any change in Croda’s underlying operations or strategic direction.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £2917.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on CRDA Stock
According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.
The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).
To see Spark’s full report on CRDA stock, click here.
More about Croda International
Croda International Plc is a specialty chemicals company that develops and supplies high-performance ingredients and technologies to sectors including consumer care, life sciences and industrial markets. The group focuses on innovative, sustainable chemistries used in products such as personal care formulations, crop protection and other advanced materials for global customers.
Average Trading Volume: 560,821
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.7B
See more insights into CRDA stock on TipRanks’ Stock Analysis page.

